Phathom Pharmaceuticals, Inc.
Develops and commercializes treatments for acid-related gastrointestinal diseases.
PHAT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US71722W1071
- LEI:
- Country:
- United States of America
- Address:
- 100 CAMPUS DRIVE,, 7932 FLORHAM PARK
- Website:
- https://www.phathompharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for acid-related gastrointestinal (GI) diseases. The company's mission is to transform the treatment landscape and improve the lives of patients with these conditions. Its primary commercial product is VOQUEZNA® (vonoprazan), a prescription medicine for adults used to treat Erosive Esophagitis and Gastroesophageal Reflux Disease (GERD). Phathom advances late-stage clinical programs to address unmet needs in gastroenterology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Phathom Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Phathom Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Phathom Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
